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CHANGES OF DRUSEN NUMBER AND CENTRAL 
RETINAL THICKNESS IN AGE-RELATED MACULAR 
DEGENERATION PATIENTS OVER TWO YEARS
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SUMMARY – Age-related macular degeneration (ARMD) is the leading cause of blindness in 
developed world but there are still much unknown facts about the disease itself. Age, genetic factors 
and smoking are the three main risk factors for the development of ARMD, but the exact patho-
physiological mechanism of the disease remains unknown. Current high resolution optical coherence 
tomography devices provide ample new information on retinal layers, drusen characteristics and their 
interaction. In this study, we analyzed 44 eyes with drusiform dry ARMD using high resolution opti-
cal coherence tomography over a 2-year period. Our results showed a statistically signifi cant increase 
in drusen number in both females and males in the 2-year period. On average, increment by 4 and 5 
drusen per eye during the 2-year period was recorded in female and male patients with drusiform dry 
ARMD, respectively. Also, statistical analysis of the central retinal thickness showed that women with 
drusiform dry ARMD had a statistically signifi cantly thinner macula than their male counterparts.
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Introduction
Age-related macular degeneration (ARMD) is a 
progressive, multifactorial, neurodegenerative disease 
and one of the leading causes of blindness in devel-
oped world. It is an elderly population disease. Ap-
proximately 10% of the population older than 65 years 
has some form of ARMD1. Older age as the most sig-
nifi cant risk factor for ARMD, together with genetic 
predisposition and smoking, makes favorable condi-
tions for ARMD appearance1-6. Th ere are two types of 
ARMD, nonexudative or dry and exudative or wet 
one. Dry form of ARMD disorder of macula is char-
acterized by one or more of the following fi ndings: 
retinal pigment epithelium (RPE) abnormalities and 
drusen or areas of geographic atrophy. Patients diag-
nosed with dry form of ARMD have mild disturbanc-
es in the quality of vision. Th ey may complain of dis-
crete blurring of vision, changed color perception or 
altered contrast sensitivity. Over years, most patients 
with dry ARMD remain in dry stage of the disease but 
notice some degree of disease progression, which may 
aff ect their daily activities (car driving, social activities, 
etc.) and the quality of life7. It is still not known for 
sure what mechanism of vision is worsening in pa-
tients remaining in dry form of the disease. On the 
other hand, if patients with dry form convert to the 
wet form, they experience signifi cant and rapid wors-
ening of vision due to the formation of neovascular 
membrane in macula8.
Normal function of retinal photoreceptors in mac-
ula requires healthy auxiliary structures, RPE, Bruch 
membrane (BrM) and choroid. RPE cells envelop and 
phagocytize outer parts of photoreceptors, deliver nu-
trient for photoreceptors, but also serve as a barrier 
that protects photoreceptors from unfavorable factors 
from the choroid. Under RPE lies Bruch membrane, a 
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structure made of extracellular matrix and with a simi-
lar role as RPE concerning protection of photorecep-
tors. Drusen, the hallmark of dry form of ARMD, are 
situated between RPE and Bruch membrane and are 
mostly made of lipids (40%) and various proteins9. It is 
still not known for certain which cells participate in 
the forming of drusen. Some studies suggest that dru-
sen originate from RPE, other suggest that they origi-
nate from choriocapillaris, but the most likely option is 
that both RPE and choroid participate in drusen for-
mation. 
Before the optical coherence tomography (OCT) 
era, drusen were graded upon their width (small, inter-
mediate or large) and appearance (soft, hard or confl u-
ent) on color fundus photography or with indirect 
ophthalmoscopy10. Today’s high resolution OCT is a 
fast noninvasive noncontact and most frequently used 
tool for analyzing macular structure11. Compared to 
standard indirect ophthalmoscopy, it provides much 
more information on retinal layers and drusen charac-
teristics, e.g., central retinal thickness (CRT), height, 
width, refl ectivity, homogeneity, and photoreceptor 
and RPE atrophy12,13. It is well known that the number 
of drusen increases over time but we found no study so 
far to quantify increase in drusen number in patients 
with dry ARMD14. In a prospective fashion, the pres-
ent study compared changes in drusen number and 
CRT in male and female subjects over a period of 2 
years.
Patients and Methods
In our prospective study that lasted for 2 years, we 
enrolled 44 eyes of 27 patients (20 female and 7 male 
patients) having dry drusiform ARMD. In 17 patients, 
both eyes (left and right) were enrolled in the trial, 
while in another 10 patients we enrolled just one eye. 
Patients diagnosed with drusiform dry ARMD on 
fundus examination were screened for inclusion crite-
ria. After dilating pupils using 1 drop of tropicamide 
and 1 drop of phenylephrine hydrochloride at 10-min-
ute interval, we performed OCT scans of macular area. 
We included eyes in which drusen were confi rmed on 
OCT scan in the absence of wet ARMD signs and if 
the average quality of scans was 5 or higher. Non-in-
clusion criteria were any other macular or other eye 
disease (high myopia, glaucoma, epiretinal membrane, 
etc.), dense cataract or opaque vitreous causing the 
scan quality to be lower than 5. Th e device used for 
OCT scanning was Optopol Copernicus. It is an SD 
OCT with luminescent diode of 840 nm, with 25000 
scans in one second, axial resolution of 6 microns and 
transverse resolution of 12 microns. We scanned dru-
sen using 3 D, 6x6 mm macular mode centered on fo-
vea. Two years later, OCT examination was repeated 
on the same device in the same fashion. Although we 
graded every drusen for height, width, refl ectivity and 
homogeneity, we were mostly interested in fi nding out 
what was the rate of progression in drusen number 
over 2-year period and if there were any gender diff er-
ences on comparing CRT.
Statistical analysis 
Descriptive statistics was applied for all variables. 
In all statistical analyses, the level of signifi cance was 
set at p=0.05. Th e study sample consisted of 27 pa-
tients, 20 women and seven men. In four of seven male 
patients, we enrolled just 1 eye each (3 right eyes and 1 
left eye). Also, only one 1 eye was enrolled in six of 20 
female patients (3 right and 3 left eyes). Diff erences in 
the number of drusen and CRT before and after 2-year 
period were tested with pair test for each eye sepa-
rately. For comparing total drusen number and CRT 
according to gender at 2-year period we used ANOVA 
for repeated measurements separately for the right and 
left eye. 
Results
Th e study included 27 subjects, 20 female and sev-
en male, mean age 67.86 (±8.11) and 70 (±6.01) years, 
respectively. Th ere was no statistically signifi cant age 
diff erence between male and female patients (t=0.74, 
p=0.468).
Signifi cant diff erence was found in drusen number 
over 2-year period for both the right and left eye. Th e 
mean diff erence for the right eye was 4.17 and for the 
left eye 5.05. In other words, the mean increase in dru-
sen number in patients with drusiform dry ARMD 
was 4.17 drusen for the right eye and 5.05 drusen for 
the left eye over 2-year period (Table 1).
Th ere was no statistically signifi cant diff erence in 
CRT at 2 years either for the right or for the left eye, 
although data showed that after 2-year period the val-
ues of CRT for the right eye were somewhat lower and 
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for the left eye somewhat higher as compared with the 
baseline values (Table 1). 
Analysis of variance of repeated measurements 
showed CRT to diff er statistically signifi cantly be-
tween men and women (Table 2, Fig. 1). Women had 
a signifi cantly lower CRT irrespective of the eye and 
time of measurement. Figure 2 shows that 95% confi -
dence intervals were narrower in women than in men, 
which can be explained by the predominance of wom-
en in the sample. Analysis of CRT showed the interac-
tion between measurement and gender to be statisti-
cally signifi cant and indicated that measurements ob-
tained at 2-year interval diff ered between genders. Not 
Table 1. Descriptive statistics and pair test results for drusen number and central retinal thickness (CRT) in two-year 
period for both eyes 




At 2 years 23.57 20.25 23 -4.17 8.12 -2.46 0.022
Left eye 
drusen number 
Initial 18.67 16.17  
At 2 years 23.71 20.23 21 -5.05 6.14 -3.76 0.001
Right eye CRT Initial 240.36 44.11  At 2 years 238.59 32.82 22 1.77 19.23 0.43 0.670
Left eye CRT Initial 248.16 34.98  At 2 years 252.84 40.30 19 -4.68 11.88 -1.72 0.103
CRT = central retinal thickness
Table 2. Analysis of variance of repeated measurement 





Initial-at 2 years 
(R-L) 2.75 0.054
Initial-at 2 years 
* gender 2.28 0.092
CRT
Gender 20.04 0.001
Initial-at 2 years 
(R-L) 3.26 0.032
Initial-at 2 years 
* gender 6.34 0.001
CRT = central retinal thickness; R-L = right-leftCRT = central retinal thickness
Fig. 1. Diagram of mean and 95% confi dence interval 
for central retinal thickness (CRT) in both eyes in 2-year 
period.
Fig. 2. Diagram of mean and 95% confi dence interval 
for drusen number for both eyes in 2-year period.
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only that CRT was lower in women but CRT in the 
left eye showed slight increase as compared to the 
right eye, whereas in men the results were opposite, i.e. 
CRT was lower in the left eye than in the right eye.
Concerning diff erence in drusen number and gen-
der, our data showed no signifi cant gender diff erence 
in drusen number. Th e interaction showed no statisti-
cal diff erence either, pointing out the fact that the 
number of drusen did not diff er according to gender at 
2-year interval (Table 2, Fig. 2). However, at 2 years 
the number of drusen was higher in both eyes.
Discussion
According to the World Health organization re-
port from 2004, ARMD is the third cause of blindness 
in the world (8.7%)15,16. What makes the problem of 
ARMD even more important is longer life expectancy, 
especially in developed countries, which implies an in-
crease in the number of ARMD patients. It is esti-
mated that by the year 2040, 288 million people 
worldwide will have some form of ARMD17. Although 
thousands of reports have been published concerning 
the course of dry form of disease, still plenty of ques-
tions regarding drusen and their behavior over time 
are waiting to be answered. 
Age related disease study 1 and 2 (AREDS 1 and 
AREDS 2) and other studies before OCT era were 
very important in terms of sorting out drusen based on 
their morphological characteristics on fundus photog-
raphy or indirect ophthalmoscopy and recognizing the 
ones that are more prone to progress to advanced stag-
es of ARMD (atrophy or wet form). Th ose studies also 
acknowledged the benefi t of taking high levels of vita-
mins and antioxidants in patients with dry form of 
ARMD for postponing disease progression18. Unfor-
tunately, at the time of conducting those trials, OCT 
scans were not included in research and all conclusions 
on the course and risk factors for disease progression 
were based upon fundus color photography. Indirect 
ophthalmoscopy and color photography of fundus are 
insuffi  cient tools for diagnosing subtle changes in dru-
sen morphology and therefore insuffi  cient for observ-
ing drusen changes in dry form of ARMD over time. 
It was the advent of high resolution OCT devices that 
started to provide plenty of new information about 
retinal layers and drusen characteristics. In the past de-
cade, there were a great number of studies that had 
been investigating the relation of drusen to RPE and 
various retinal layers. Many of these studies confi rmed 
dynamic changes of drusen over time. Studies with 
high resolution OCT have discovered that over time 
drusen may regress, enlarge or stay the same, some 
drusen may be related to photoreceptor or RPE atro-
phy, and some studies have confi rmed the pre-OCT 
era studies reporting that a large number of drusen and 
large diameter of drusen are more likely do lead to ad-
vanced stages of ARMD12,18-21. On searching the lit-
erature, we found no study that compared changes in 
drusen number and CRT in patients with dry drusi-
form ARMD over a period of time. 
Our study showed that in a patient with dry form 
of ARMD, drusen number increased by approximately 
4 drusen in the right eye and 5 drusen in the left eye 
during a 2-year period. Th is is interesting information 
because, to the best of our knowledge, the increase in 
drusen number over years was quantifi ed for the fi rst 
time. Although drusen may disappear, regress, enlarge, 
stay the same or completely new drusen may appear 
with time, we showed that the overall number of dru-
sen in our age group generally increased. Th e question 
remains whether this increment in drusen number by 
itself could be associated with the loss of vision in dry 
form ARMD or other pathological changes in retina 
and RPE need to occur as well. 
In our study, we also compared CRT between gen-
ders and recorded some interesting results. We found 
that women with drusiform dry ARMD had a statisti-
cally signifi cantly thinner macula (CRT) than men. 
Although we do not know the reason for such a diff er-
ence, it might be interesting to point out that some 
earlier researches carried out on healthy subjects also 
found women to have thinner macula than men. In 
this context, our result might not be associated to 
ARMD but rather to being female22-25. Some authors 
argue that thinner macula in women might be attrib-
uted to hormonal changes in menopause and even 
propose that female gender could be a risk factor for 
other macula diseases such as macular holes26,27. In the 
Beaver Dam Eye Study, macular thickness in women 
taking oral estrogen was on average 4 μm greater than 
in women not taking oral estrogen, although this dif-
ference did not reach statistical signifi cance23. Th is 
fi nding may have important implications because dif-
ference in thickness between men and women in dry 
ARMD may have an impact on visual function. Gen-
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der diff erences in CRT in dry ARMD found in our 
study should therefore be taken into consideration 
when performing macular analysis on OCT device. 
For future studies, it would be interesting to compare 
CRT and visual acuity between men and women, as 
well as to compare the rate of progression to advanced 
stages of disease between genders.
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Sažetak
PROMJENE BROJA DRUZA I SREDIŠNJE MREŽNIČNE DEBLJINE 
U BOLESNIKA SA SENILNOM MAKULARNOM DEGENERACIJOM KROZ DVIJE GODINE
K. Mandić, N. Vukojević, T. Jukić, D. Katušić i J. Juri Mandić
Iako je senilna makularna degeneracija (SMD) vodeći uzrok sljepoće u razvijenom svijetu, još uvijek postoje mnoge 
 nepoznanice oko nastanka i tijeka bolesti. Visoka životna dob, genetska predispozicija i pušenje najvažniji su čimbenici rizika 
za nastanak bolesti. Moderna optička koherentna tomografi ja visoke rezolucije (engl. optical coherence tomography, OCT) 
pruža mnogo novih informacija o retinalnim slojevima, karakteristikama druza i njihovoj uzajamnoj interakciji. U ovom 
istraživanju usporedili smo nalaze OCT u 44 oka bolesnika koji boluju od suhe druziformne SMD kroz razdoblje od 2 godi-
ne. Otkrili smo da se broj druza kroz 2 godine kod žena prosječene dobi od 70 godina uvećao za 4 druze, dok se kod muška-
raca prosječne dobi od 68 godina broj druza u istom razdoblju povećao za 5 druza. Uspoređujući centralnu retinalnu debljinu 
kod muškaraca i žena otkrili smo da žene imaju statistički značajno tanju centralnu retinalnu debljinu od muškaraca.
Ključne riječi: Makularna degeneracija, starija dob; Retina, druze; Retina; Spol; Muška osoba; Ženska osoba
